Results 261 to 270 of about 592,769 (337)

Stroke in Dilated Cardiomyopathy: An Autopsy-Based Study of Mechanisms, Topography, and Clinical Implications. [PDF]

Diagnostics (Basel)
Țica O, Sabău M, Venter A, Beiușanu C, Berechet M, Huniadi A, Șandor MI, Țica O.   +7 more
europepmc   +1 more source

Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy [PDF]

, 2016
Borgeat, K A, Brodbelt, D C, Connolly, D J, Fuentes, V L, Payne, J R   +4 more
core   +1 more source

Mitochondrial Ca2+ overload is a pivotal risk factor for lethal ventricular arrhythmias due to the oxidation of mitochondrial respirasome and energetic failure

British Journal of Pharmacology, EarlyView.
The data that support the findings of this study are available from the corresponding author upon reasonable request. Some data may not be made available because of privacy or ethical restrictions. Background and Purpose Ventricular arrhythmias are a leading cause of death among patients with cardiovascular diseases and are associated with elevated ...
Felipe de Jesús Salazar‐Ramírez, Luis Alberto Luévano‐Martínez, Abraham Méndez‐Fernández, Judith Bernal‐Ramírez, Carolina A. Morales‐Ochoa, Christian Silva‐Platas, Alfredo Cabrera‐Orefice, Ana C. Murrieta, José Luis Velasco‐Bolom, Gricelda Mendiola‐Garza, Flavio Contreras‐Torres, Guillermo Torre‐Amione, Ernesto A. Aiello, Gerardo García‐Rivas   +13 more
wiley   +1 more source

Methylome-driven regulation of miRNA expression and its relationship to cardiac dysfunction in idiopathic dilated cardiomyopathy. [PDF]

Clin Epigenetics
Gallego-Martínez A, Delgado-Arija M, González-Torrent I, Pérez-Carrillo L, Benedicto-Marrero C, Bodí-Miret J, Portolés M, Tarazón E, Roselló-Lletí E.   +8 more
europepmc   +1 more source

An optimized plasmalogen modulating dietary supplement provides greater protection in a male than female mouse model of dilated cardiomyopathy

T. Belkin, Emma Masterman, Gunes S. Yildiz, Helen Kiriazis, Natalie A Mellett, Jonathon Cross, K. Grigolon, A Dogra, D. Donner, Roger Chooi, Amy Liang, Andrew R. Kompa, Junichi Sadoshima, Amanda J. Edgley, David W. Greening, Peter J. Meikle, Yow Keat Tham, Julie R. McMullen   +17 more
openalex   +1 more source

Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy.

Heart Failure Clinics, 2018
Amanda C Garfinkel, J. Seidman, C. Seidman   +2 more
semanticscholar   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

An African ancestry-specific nonsense variant in CD36 is associated with a higher risk of dilated cardiomyopathy. [PDF]

Nat Genet
Huffman JE, Gaziano L, Al Sayed ZR, Judy RL, Raffield LM, Biddinger KJ, Charest B, Chopra A, Gagnon D, Guo X, Koledova V, Levin MG, Min YI, Pirruccello JP, Reza N, Ruan R, Verma SS, Venkatesh BA, Verma A, Yao J, Carr JJ, Casas JP, Cho K, Lima JAC, Post WS, Rader DJ, Ritchie MD, Shah A, Taylor KD, Terry JG, Rich SS, O'Donnell CJ, Phillips LS, Lunetta KL, Rotter JI, Wilson PWF, Gaziano JM, Damrauer SM, VA Million Veteran Program, Sun YV, Ellinor PT, Joseph J, Aragam KG.   +42 more
europepmc   +1 more source

Implantable cardioverter defibrillator resistant mortality in ischemic and dilated cardiomyopathy across therapeutic eras: a single, tertiary center experience [PDF]

Maarten Blondeel, Gábor Vörös, Christophe Garweg, P Haemers, Joris Ector, Tomas Robyns, Rik Willems, Bert Vandenberk   +7 more
openalex   +1 more source

Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases

Cell Proliferation, EarlyView.
HDACs play an important role in the occurrence and development of cardiovascular diseases, such as myocardial hypertrophy, hypertension, and atherosclerosis. HDAC inhibitors have broad prospects for the treatment of CVD, and different HDAC subtypes can act through different mechanisms.
Li‐Ying Zhang, Yue‐Yue Wang, Ri Wen, Tie‐Ning Zhang, Ni Yang   +4 more
wiley   +1 more source